Biohaven Corp (BHVN): O‘sish sur’atiga tuzatilgan narx-foyda
Biohaven Ltd. fidoyi neyrobiologlardan iborat barqaror xodimlar tarkibiga tayangan holda, markaziy nerv tizimi terapiyalarining keng spektri orqali risklarni minimallashtiradi. Normallashtirilgan PEG koeffitsiyenti baholash va biznesning o'sish sur'atlari o'rtasidagi bog'liqlikni vizuallashtiradi, bunda 0.00 joriy darajani ko'rsatadi. Yangi dori formulalarini kashf qilish samaradorligi bu yerda avtomatlashtirilgan bioinformatik nishon tahlili tizimlarining joriy etilishi orqali ta'minlanadi.
Biohaven Ltd. (BHVN) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Biohaven Ltd.|BHVN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati biohavenpharma.com|BHVN - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Biohaven Pharmaceutical|BHVN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Biohaven|Tezkor likvidlik biohavenpharma.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
BHVN - Sof daromad|Kelajakdagi sof foyda Biohaven Ltd.|BHVN - P/E multiplikatori|Narxning kelajakdagi foydaga nisbati Biohaven Corp|BHVN - Narx-foyda va o‘sish multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Biohaven Pharmaceutical|BHVN - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Biohaven|BHVN - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi biohavenpharma.com|BHVN - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Biohaven Ltd.
Kompaniyaning fundamental tahlili:Biohaven Ltd (BHVN)
PEG koeffitsiyenti joriy P/E ko'paytirgichini foyda o'sish sur'ati bilan solishtiradi, bu esa investorlarga kelajakdagi biznes kengayishi uchun haddan tashqari ko'p to'layotganlarini aniqlash imkonini beradi. Adolatli qiymat PEG dinamikasini tahlil qilish orqali Kv7 platformasi yordamida nevrologik buzilishlar terapiyasi sohasidagi nishalarni egallash samaradorligini baholash mumkin, bu esa Biohaven Ltd. (BHVN) kompaniyasining innovatsion loyihalar portfelining kengayish sur'atiga nisbatan past baholanganligini ochib beradi.
Biohaven Ltd. kimlar bilan raqobatlashadi
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Biogen Inc|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|Regencell Corp (RGC) - O‘sish sur’atiga tuzatilgan narx-foyda|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACAD (acadia-pharm.com)|XENE: PEG multiplikatori|Viking Therapeutics Inc (VKTX) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori SUPN|Narxning foydaga va o‘sish sur’atiga nisbati CPRX|PEG multiplikatori DNLI|HRMY - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Amylyx Pharmaceuticals, Inc. AMLX|TRVI: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PRAX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CeriBell, Inc. (CBLL) - Narxning foydaga va o‘sish sur’atiga nisbati|PRTA (Prothena) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori ALEC|ANNX (Annexon Biosciences) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori OMER|Neurogene Therapeutics - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AC Immune - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. - PEG multiplikatori|SCLX: Narxning foydaga va o‘sish sur’atiga nisbati|TVGN: PEG multiplikatori|Alpha Cognition Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori CGTX|Narxning foydaga va o‘sish sur’atiga nisbati IKT|Narxning foydaga va o‘sish sur’atiga nisbati Cassava Sciences (SAVA)|assertiotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Coya Therapeutics COYA|VTGN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Ovid Rx - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda acumenpharm.com|CRVO (CervoMed) - Narx-foyda va o‘sish multiplikatori|Alterity Therapeutics Limited (ATHE) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|PEPG: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|RLMD - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ANVS (Annovis Bio)|Grace Therapeutics Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Firefly Neuroscience Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Klotho Neurosciences Inc KLTO|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|MTVA (MetaVia Inc.) - PEG multiplikatori|NRXS: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori HSDT|PEG multiplikatori passagebio.com (PASG)|Neuphoria Therapeutics - Narx-foyda va o‘sish multiplikatori|minervaneurosciences.com - Narxning foydaga va o‘sish sur’atiga nisbati|Athira Pharma - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Addex Therapeutics Ltd.|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CYCN|Narx-foyda va o‘sish multiplikatori PTIX|KTTA: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|Narxning foydaga va o‘sish sur’atiga nisbati ATXI (Avenue Therapeutics Inc.)|Brainstorm Cell Therapeutics, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati CARA (Cara Therapeutics Inc)|Chromocell Therapeutics - PEG multiplikatori|ELYM (Eliem Therapeutics) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ITCI (intracellulartherapies.com) - Narx-foyda va o‘sish multiplikatori|LBPH - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|MRNS (Marinus) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati NKGN|PEG multiplikatori NRBO|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Synaptogenix - Narx-foyda va o‘sish multiplikatori|Trevena Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|WENA (Anew Medical Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
